Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities
Céline M. Laumont, Allyson C. Banville, Mara Gilardi, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 7, pp. 414-430
Open Access | Times Cited: 286

Showing 26-50 of 286 citing articles:

Identification of endothelial-related molecular subtypes for bladder cancer patients
Dengxiong Li, Dechao Feng, Xu Shi, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 23
Tertiary Lymphoid Structure Raises Survival and Immunotherapy in HPV− HNSCC
Hao Li, S.-W. Zhu, Jiehua Zhou, et al.
Journal of Dental Research (2023) Vol. 102, Iss. 6, pp. 678-688
Closed Access | Times Cited: 22
The tumor microenvironment: shaping cancer progression and treatment response
Sharav Desai, Vipul P. Patel, Kunal Bhosle, et al.
Journal of Chemotherapy (2024), pp. 1-30
Closed Access | Times Cited: 11
Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma
Yang Liu, Shuangyan Ye, Shuai He, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy
Giulia Petroni, Serena Pillozzi, Lorenzo Antonuzzo
Cancer Research (2024) Vol. 84, Iss. 8, pp. 1199-1209
Open Access | Times Cited: 10
Decoding the spatiotemporal heterogeneity of tumor-associated macrophages
Xiangyuan Chu, Yu Tian, Chao Lv
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Multi-stage mechanisms of tumor metastasis and therapeutic strategies
Zaoqu Liu, Jingqi Chen, Yuqing Ren, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Single-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid structures in muscle-invasive bladder cancer
Hao Yuan, Xingning Mao, Y. Yan, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Glycolysis in the tumor microenvironment: a driver of cancer progression and a promising therapeutic target
Junpeng Zhao, Dandan Jin, Mengxiang Huang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 8
Intratumoral CD38+CD19+B cells associate with poor clinical outcomes and immunosuppression in patients with pancreatic ductal adenocarcinoma
Heng Zhu, Jin Xu, Wei Wang, et al.
EBioMedicine (2024) Vol. 103, pp. 105098-105098
Open Access | Times Cited: 7
Mapping the complexity and diversity of tertiary lymphoid structures in primary and peritoneal metastatic gastric cancer
Tessa S. Groen-van Schooten, Rosalia Franco Fernandez, Nicole C.T. van Grieken, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e009243-e009243
Open Access | Times Cited: 7
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?
Wolf H. Fridman, Sophie Sibéril, Guilhem Pupier, et al.
Seminars in Immunology (2022) Vol. 65, pp. 101703-101703
Open Access | Times Cited: 36
The Cancer Epitope Database and Analysis Resource (CEDAR)
Zeynep Koşaloğlu, Nina Blazeska, Randi Vita, et al.
Nucleic Acids Research (2022) Vol. 51, Iss. D1, pp. D845-D852
Open Access | Times Cited: 35
Radiotherapy-activated tumor immune microenvironment: Realizing radiotherapy-immunity combination therapy strategies
Haifen Luo, Wen Ma, Qi Chen, et al.
Nano Today (2023) Vol. 53, pp. 102042-102042
Closed Access | Times Cited: 20
Immunometabolic reprogramming, another cancer hallmark
Vijay Kumar, John H. Stewart
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Current state-of-the-art on ganglioside-mediated immune modulation in the tumor microenvironment
Irene van der Haar Àvila, Britt Windhouwer, Sandra J. van Vliet
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 941-958
Open Access | Times Cited: 16
Germinal center-dependent and -independent immune responses of tumor-infiltrating B cells in human cancers
Eve Playoust, Romain Remark, Éric Vivier, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 9, pp. 1040-1050
Open Access | Times Cited: 15
Cellular dynamics in tumour microenvironment along with lung cancer progression underscore spatial and evolutionary heterogeneity of neutrophil
Haoxin Peng, Xiangrong Wu, Shaopeng Liu, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 7
Open Access | Times Cited: 15
Unraveling the complex interplay between anti-tumor immune response and autoimmunity mediated by B cells and autoantibodies in the era of anti-checkpoint monoclonal antibody therapies
Sarah Soussan, Guilhem Pupier, Isabelle Cremer, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
The role of tertiary lymphoid structure and B cells in nasopharyngeal carcinoma: Based on bioinformatics and experimental verification
Chujun Chen, Yan Zhang, Xiaoting Wu, et al.
Translational Oncology (2024) Vol. 41, pp. 101885-101885
Open Access | Times Cited: 6
Two Hematological Markers Predicting the Efficacy and Prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast Cancer
Cheng Wang, Qiyun Shi, Guozhi Zhang, et al.
The Oncologist (2024) Vol. 29, Iss. 5, pp. e635-e642
Open Access | Times Cited: 6
Germinal center B-cell subgroups in the tumor microenvironment cannot be overlooked: their involvement in prognosis, immunotherapy response, and treatment resistance in head and neck squamous carcinoma
Lin Li, Jiani Zou, Shengbin Pei, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e37726-e37726
Open Access | Times Cited: 6
Identification and characterization of CLEC11A and its derived immune signature in gastric cancer
Qing Yin Zheng, Zhenqi Gong, Baizhi Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling
Yunxing Shi, Zongfeng Wu, Shaoru Liu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Epigenetic therapies targeting histone lysine methylation: complex mechanisms and clinical challenges
Sarah Gold, Ali Shilatifard
Journal of Clinical Investigation (2024) Vol. 134, Iss. 20
Open Access | Times Cited: 5

Scroll to top